Podcasts about Ras

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: It's World Diabetes Day and we have a LOT of news to get to! Daily oral insulin tested to prevent T1D, mothers and sons and a T1D link, stem cell updates, Tandem Android news, Omnipod's workplace campaign and more! Find out how to submit your Community Commercial Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. It's world diabetes day! It is marked every year on 14 November, the birthday of Sir Frederick Banting, who co-discovered insulin along with Charles Best in 1922.   WDD was created in 1991 by International Diabetes Federation (IDF) and the World Health Organization and became an official United Nations Day in 2006 with the passage of United Nations Resolution 61/225. There will be a ton of stuff in your feeds today and that's great! I'm going to keep this to a pretty normal in the news episode.. although I do have my own World Diabetes Day announcement – I want YOUR community commercials. You could have an ad for your event or your blog or your project right here! There's a post on the website explaining it all and I'll come back at the end of the episode and tell you more. XX The Primary Oral Insulin Trial (POInT) is the first large-scale clinical trial to test whether giving at-risk children daily oral insulin could prevent or delay type 1 diabetes (T1D). Conducted by researchers from Helmholtz Munich and the Technical University of Munich across five European countries, the study enrolled more than 1,000 children with a genetic risk for T1D. Results published in The Lancet show that while oral insulin did not prevent the development of islet autoantibodies—an early sign of diabetes—it was safe and well tolerated. Importantly, researchers found that some children who received oral insulin developed diabetes more slowly than those given a placebo, suggesting potential protective effects in certain genetic subgroups.   Further analysis revealed that the response to treatment depended on the child's insulin gene variant. Children with genetic versions that raise diabetes risk appeared to benefit, showing delayed onset of the disease, while those without the risk variant did not. These findings point toward a future of personalized prevention, where genetic screening could help identify which children might benefit most from oral insulin. Researchers will continue following the participants until age 12 to assess long-term effects. The study marks a major milestone in decades of diabetes prevention research, highlighting both the promise and complexity of developing tailored, early interventions against type 1 diabetes. XX Joint US-Chinese research looking at generating new beta cells from stomach cells. Upon turning on the "genetic switch," the human stomach cells were converted to insulin-secreting cells within the mice and resembled pancreatic beta cells with respect to gene and protein expression. Encouragingly, when those experiments were done with diabetic mice, insulin secreted from the transformed human cells helped control blood sugar levels and ameliorated diabetes. The scientists hope that a similar approach can be taken to convert cells from a patient's own stomach into insulin-secreting cells directly within the body. Importantly, additional studies are needed to address if this approach is safe and effective to be used in patients. https://www.technologynetworks.com/cell-science/news/human-stomach-cells-tweaked-to-make-insulin-406694 XX A new study in Nature Metabolism may help explain why children born to mothers with type 1 diabetes are less likely to develop the disease early in life compared to those whose fathers or siblings have it. Researchers looked at nearly 2,000 mothers and their children and found that  kids whose moms have type 1 diabetes show changes in their DNA that may actually help protect them. These aren't genetic mutations, but epigenetic changes — chemical tags that turn certain genes on or off. The study found these changes in genes tied to the immune system and type 1 diabetes risk, suggesting that a mother's condition during pregnancy can shape her child's immune response in a protective way. Scientists identified more than 500 areas of DNA where these changes occurred, many in regions that control how the body's immune system works. Most of the changes appeared to calm down the kind of overactive immune response that leads to type 1 diabetes. Researchers even created a "methylation score" to help measure this protective effect. They say the next step is to confirm these results in more diverse groups and figure out exactly how these DNA changes help prevent early diabetes. https://www.news-medical.net/news/20251110/Maternal-type-1-diabetes-may-protect-children-from-developing-the-disease.aspx XX A new study from Karolinska Institutet and Stockholm University reveals that sons born to mothers with type 1 diabetes may develop early vascular dysfunction—independently of metabolic health. The finding may help shape future strategies to prevent cardiovascular disease early in life.     Children of women with type 1 diabetes are known to be at increased risk of developing cardiovascular diseases. This new study, published in Cell Reports Medicine, is the first to show that the risk is linked to early dysfunction in blood vessel cells in sons, even before any metabolic issues arise. The team is now investigating the long-term effects of maternal diabetes, with a particular focus on why sons seem to be affected earlier than daughters. https://medicalxpress.com/news/2025-11-sons-mothers-diabetes-early-vascular.html XX A new study presented at Kidney Week 2025 has shown that the drug finn-uh-near-own  a nonsteroidal mineralocorticoid-receptor antagonist, significantly reduced albuminuria—a key marker of kidney damage—in people with type 1 diabetes (T1D) and chronic kidney disease (CKD). This is the first major breakthrough for this population in more than 30 years. Researchers found that patients taking finerenone saw a 25% average reduction in albuminuria compared to placebo, an improvement that suggests a lower long-term risk for dialysis or kidney transplant. The phase 3 FINE-ONE trial involved 242 adults with T1D and CKD, and results showed benefits as early as three months. The drug was generally well tolerated, with side effects similar to those seen in patients with type 2 diabetes, though mild hyperkalemia (high potassium levels) was slightly more common. Experts say the findings could change the way doctors treat kidney complications in type 1 diabetes, an area that hasn't seen new therapies since the early 1990s. Currently, treatment options rely on blood pressure and blood sugar management, along with renin-angiotensin system (RAS) inhibitors. Finerenone, which is already approved for type 2 diabetes-related CKD, targets overactivation of a receptor that drives kidney damage. Based on these results, Bayer plans to seek FDA approval in 2026 for use in people with T1D and CKD. Researchers and clinicians alike are calling the study "groundbreaking," noting that it opens the door to future research on how finerenone might not just slow kidney decline—but possibly prevent it altogether. https://www.medscape.com/viewarticle/finerenone-offers-hope-kidney-disease-type-1-diabetes-2025a1000uzi?form=login   XX This week, Tandem Diabetes Care (Nasdaq:TNDM) announced a major milestone for its Mobi miniature durable insulin pump system. San Diego-based Tandem revealed that it received FDA approval for the Android version of its Mobi mobile app. Clearance brings Mobi — which the company describes as the world's smallest, durable automated insulin delivery system — to more users. The pump, which pairs with Tandem's Control-IQ+ algorithm, previously worked with iOS software.   Tandem — one of the largest diabetes tech companies in the world — expects to begin a limited rollout next month, followed by full commercial availability in early 2026. This marks the latest milestone for the company, which continues to expand its offerings and widen its reach within the diabetes patient population.   We had a great interview with Tandem on our previous episode, but as I said at the time, it was coming before their earnings call. So here's an update: The company plans to submit the tubeless mobi to the fda before the end of this year.. possible approval and shipping date is hoped for by middle of 2026. Trials for their fully closed loop next-generation algorithm which we tlkaed abou ton the show should be launched in 2026 The Sigi patch pump will be developed and launched as a next-generation version of the Mobi Great job by Dr. David ? Ahn – he posted on IG after getting a message from tandem CEO John Sheridan? 1. First, the Tandem X3 *is* still absolutely in development, contrary to my speculation In yesterday's video. As many of you appropriately pointed out, there is definitely a market for a 300 unit pump, a pump with a screen, and a pump that does not require smartphone control. So from our brief chat, the sense I got that is that the X3 would be more of a refresh of the X2 with newer components, such as a USB-C connector and better memory, rather than a total redesign from the ground up. In terms of timing, all I could get was that it was "not too far distant in the future," which could mean anything I guess, but at least it's still on the way! 2. Next up, he also reassured me that they are working closely with Dexcom to support the G7 15 Day sensor within the next few months. I suspected as much, but it's always good to hear confirmation. 3. Lastly, he did confirm that Tandem is far along in developing a Caregiver/Follow app to allow the remote viewing of glucose and insulin data from a Tandem pump. He explained that it will be based on Sugarmate, the popular diabetes data dashboard app that Tandem acquired back in Jun 2020. While I don't know if every feature will make it into the Tandem caregiver app, Sugarmate is well-liked for its highly customizable dashboard and highly configurable alerts. Sugarmate even has the option to send a text message or phone call for urgent lows. Regardless, a true follow/Caregiver app will be welcomed with open arms by all caregivers and Tandem users who use Libre 3 Plus. https://time.com/7318020/worlds-top-healthtech-companies-2025/ XX Senseonics submits Eversense 365 – their year long implantable CGM for a CE mark, European Approval and expect to launch there soon. Eversense will be integrated with the sequel twist pump – again I'm hearing soon but no timeline. Intersting to note that one year inseration was approved in the US just about a year ago, so the first patients will be having their CGMs changed out – for the first time – pretty soon. https://www.drugdeliverybusiness.com/senseonics-q2-2025-sales-beat-ce-mark/ XX A confusing study out of Rutgers - these researcher say  metformin reduces some of the key benefits normally gained from regular physical activity. These include improvements in blood vessel health, physical fitness, and the body's ability to regulate blood sugar. Since 2006, doctors have typically encouraged patients with elevated blood sugar levels to combine metformin with exercise, expecting that the two proven treatments would produce stronger results together. However, the new research suggests this may not be the case. In this study, Exercise alone improved vascular insulin sensitivity, meaning blood vessels responded better to insulin and allowed more blood flow to muscles. This matters because insulin's ability to open blood vessels helps shuttle glucose out of the bloodstream and into tissues, lowering blood sugar after meals. But when metformin was added, the improvements shrank. The drug also diminished gains in aerobic fitness and reduced the positive effects on inflammation and fasting glucose. The findings don't mean people should stop taking metformin or exercising, Malin said. Instead, it raises urgent questions for doctors about how the two treatments can be combined and the need for close monitoring. Malin hopes future research will uncover strategies that preserve the benefits of both. https://scitechdaily.com/popular-diabetes-drug-metformin-may-cancel-out-exercise-benefits-study-warns/ XX XX https://www.medtechdive.com/news/Revvity-Sanofi-diabetes-test-Kihealth-seed-round/802133/   XX Dexcom recalled an Android app for its G6 glucose sensor due to a software problem that could cause the app to terminate unexpectedly. The issue could cause users to miss alarms, alerts or notifications related to estimated glucose values, according to a Food and Drug Administration database entry posted Oct. 30. The glucose sensor and the app are still available, but Dexcom required users to update the app to a new version. Dexcom began the recall on Aug. 28. The FDA designated the event as a Class 1 recall, the most serious kind. Dexcom sent a notification to customers in September about the software bug, which applies to version 1.15 of the G6 Android app. To use the app, customers must update it to a new version, according to the entry. https://www.medtechdive.com/news/dexcom-recall-g6-cgm-app/804630/ XX https://www.medscape.com/viewarticle/automated-insulin-delivery-boosts-glycemic-control-youth-2025a1000ub3 XX Tidepool partners with smart ring maker OURA.. press release says: to support a groundbreaking dataset intended to be broadly available for diabetes research, with participation limited to individuals who opt in through Tidepool.         Tidepool will pair biometric data from Oura Ring – sleep, activity, heart rate, temperature trends, and menstrual cycles – with diabetes device data, including continuous glucose monitors (CGMs) and insulin pumps. The result will provide researchers with an unprecedented dataset to accelerate the development of new clinical guidelines, next-generation diabetes technology, and personalized care models.   Recruitment is expected to launch in early 2026 through an IRB-approved study. By opting in to this study, participants consent to sharing their data with Tidepool's Big Data Donation Project, where data is de-identified and, with participant consent, shared with academics, researchers, and industry innovators to accelerate diabetes research. https://aijourn.com/tidepool-collaborates-with-oura-to-advance-inclusive-diabetes-research-through-wearables/ XX Eli Lilly launches two new clinical trials for baricitinib. These phase 3 trials will investigate whether the drug can delay T1D onset or progression and will open for recruitment soon. Baricitinib has the potential to extend the "honeymoon period" of T1D, meaning that it could preserve remaining insulin-producing beta cells earlier in disease progression. More beta cells mean better blood sugar management—and potentially reduced long-term complications. JAK inhibitors, including baricitinib, are already FDA-approved for other autoimmune diseases, such as rheumatoid arthritis, alopecia, and more. JAK signaling pathways are associated with overactive immune responses, so blocking this pathway may turn down the immune response. The phase 2 Breakthrough T1D-funded BANDIT study was key in showing that this drug is safe and effective in T1D. Importantly, baricitinib is a once-daily oral pill—meaning its use is simple and easy.   https://www.breakthrought1d.org/news-and-updates/two-new-trials-baricitinib-to-delay-t1d/ XX   Insulet is taking diabetes awareness into the workplace. Having found 79% of people with diabetes have faced bias or misunderstanding at work, the medtech giant is rolling out a range of resources intended to trigger changes in how workplaces approach the condition. Lots going on for Diabetes Awareness month.. some notables.. Insulet's "The Day Diabetes Showed up to Work" campaign. based on a survey of almost 10,000 people 79% of people with diabetes have faced bias or misunderstanding at work,.   Almost 90% of people with diabetes surveyed reported experiencing barriers at work due to their condition, and more than 40% of people with diabetes and caregivers said they have workplace-related anxiety tied to the metabolic disease. Around one-quarter of respondents reported fears that diabetes could limit opportunities or lead to workplace discrimination and judgment, and a similar proportion of people said they conceal their condition. https://www.fiercepharma.com/marketing/widespread-workplace-challenges-people-diabetes-spark-insulet-campaign XX New directive issued by the Trump administration could mean people seeking visas to live in the U.S. might be rejected if they have certain medical conditions, including diabetes or obesity.   The guidance, issued in a cable the State Department sent to embassy and consular officials and examined by KFF Health News, directs visa officers to deem applicants ineligible to enter the U.S. for several new reasons, including age or the likelihood they might rely on public benefits.   The guidance says that such people could become a "public charge" — a potential drain on U.S. resources — because of their health issues or age.   The cable's language appears at odds with the Foreign Affairs Manual, the State Department's own handbook, which says that visa officers cannot reject an application based on "what if" scenarios, Wheeler said.   The guidance directs visa officers to develop "their own thoughts about what could lead to some sort of medical emergency or sort of medical costs in the future," he said. "That's troubling because they're not medically trained, they have no experience in this area, and they shouldn't be making projections based on their own personal knowledge or bias."   Immigrants already undergo a medical exam by a physician who's been approved by a U.S. embassy. https://www.npr.org/2025/11/12/nx-s1-5606348/immigrants-visas-health-conditions-trump-guidance XX SAN DIEGO---Nov. 14, 2025—DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today unveiled 16 new diabetes advocates to represent people living with diabetes globally as part of Dexcom's World Diabetes Day campaign. The advocates – ranging from ages six to 68, spanning various types of diabetes, and hailing from four continents and five countries – were selected from 1,000 open call submissions based on their experiences advocating for people with diabetes in their communities. While each person's experience with diabetes is unique, they share a common passion for advocacy – and use of Dexcom's glucose biosensing technology. "Through advocacy, I strive to show others, especially children and newly diagnosed patients, that diabetes is not a limitation but an opportunity to grow stronger, inspire resilience and pursue ambitious goals," said Maria Alejandra Jove Valerio, one of Dexcom's new advocates. "What began as a diagnosis at age seven has grown into a lifelong mission to uplift others." This effort represents the first time Dexcom has sourced voices from the broader diabetes community specifically for its World Diabetes Day campaign, reinforcing Dexcom's history of and commitment to giving real people with diabetes a platform to share their story on a global stage. Through engaging, editorial-style portraits and deeply personal stories, the campaign highlights each advocate's personal experience with diabetes, what misconceptions about diabetes they'd like to dispel and how they want to inspire others with diabetes to discover what they're made of. To prepare for the spotlight, the group of advocates met in Los Angeles for a World Diabetes Day photoshoot which included a surprise visit from Grammy-nominated artist, actor, producer and Dexcom Warrior Lance Bass and author, producer, actress and Stelo*Ambassador Retta. This visit offered the advocates an opportunity to exchange stories and personal perspectives on the meaning of diabetes advocacy and how they live it each day. Behind the lens at the shoot was another member of the diabetes community—photographer Tommy Lundberg who lives with Type 1 diabetes. "Directing this photoshoot was nothing short of inspiring. Each of these advocates has a unique an XX On what would have been the 100th birthday of its visionary founder Alfred E. Mann, MannKind Corporation (Nasdaq: MNKD), in partnership with Alfred E. Mann Charities and The Diabetes Link, announced the launch of the Centennial Al Mann Scholarship. The new program will distribute $100,000 in scholarship funds to support at least 10 young adult students living with diabetes as they pursue higher education in life sciences.   Launched in Diabetes Awareness Month, the scholarship program honors Alfred E. Mann's enduring legacy of innovation, philanthropy, and his lifelong commitment to improving the quality of human life through medical advancement. Deeply passionate about giving back, Mr. Mann believed that his success should continue to serve humanity long after his passing, a belief that lives on through this initiative.   Each scholarship recipient will be awarded up to $10,000, distributed in annual installments of $2,500 throughout the course of their studies. Depending on the length of their degree program, recipients may receive between two and four installments (up to the full $10,000 per student). The first awards will be made for the 2026 academic year.   "Al Mann dedicated his life to helping people with serious medical conditions live longer, healthier lives. This scholarship is a reflection of that spirit," said Michael Castagna, PharmD, Chief Executive Officer of MannKind Corporation. "By supporting students living with diabetes who are pursuing careers in the life sciences and adjacent fields, we're honoring Al's legacy and investing in the future of innovation and care. This program is about giving back to the community we serve and empowering the next generation to carry forward Al's mission of making a meaningful difference in people's lives."   Alfred E. Mann Charities and MannKind will partner with The Diabetes Link to launch the program to serve young adults (aged 18-22) living with either type 1 or type 2 diabetes with their higher education goals. Those eligible will include incoming freshmen and current students pursuing 2- or 4-year degrees. The application window will open in early 2026, and for those interested in receiving notifications, an early interest form is available. More information about the scholarship will be shared on thediabeteslink.org.   "We're honored to partner with MannKind to expand access to higher education for young adults with diabetes," said Manuel Hernández, Chief Executive Officer of The Diabetes Link. "At a time when the cost of college continues to rise, this scholarship helps ease the financial burden and carries forward the spirit of Al Mann, whose vision and legacy continue to inspire us."   Mr. Mann was MannKind's Chairman of the Board from 2001 until his passing in February 2016 and served as Chief Executive Officer from November 2003 until January 2015. Driven by a desire to improve lives and fill unmet medical needs, for more than six decades he founded 17 companies and developed breakthrough medical devices, including insulin pumps, cochlear implants, cardiac pacemakers and retinal prostheses. In 1997, Mr. Mann saw the potential of a dry powder insulin formulation to change the way diabetes is treated and invested nearly $1 billion to help bring Afrezza® (insulin human) Inhalation Powder to market.   About MannKind MannKind Corporation (Nasdaq: MNKD) is a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient-centric solutions. Focused on cardiometabolic and orphan lung diseases, we develop and commercialize treatments that address serious unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease.   With deep expertise in drug-device combinations, MannKind aims to deliver therapies designed to fit seamlessly into daily life.   Learn more at mannkindcorp.com.   About Alfred E. Mann Charities, Inc. Alfred E. Mann Charities, Inc. became active in 2016, following the passing of the organization's benefactor, Alfred E. Mann. Throughout his life, Al was passionate about philanthropy and was dedicated to prolonging and improving the quality of human lives through innovation in the fields of healthcare and the use of medical devices. It was important to Al that his success and assets continue to better human lives even after his own passing.   Alfred E. Mann Charities, Inc. (formerly known as Alfred E. Mann Family Foundation) has similarly placed its primary focus on healthcare and medical innovation, as our organization believes this is where we can have the greatest impact on humanity and human health throughout the world. Alfred E. Mann Charities, Inc. is also dedicated to promoting arts, culture, education, and community development across Los Angeles and throughout the world in order to best serve people and this planet.   Learn more at aemanncharities.org.   About The Diabetes Link The Diabetes Link is the only national nonprofit organization dedicated to empowering young adults living with diabetes. Founded by and for young adults, The Link serves this community through peer support, leadership opportunities, and practical, evidence-based resources designed for real life. Its network of campus and community chapters, active online community, and robust Resource Hub help young adults navigate the transitions of early adulthood while managing diabetes. The organization envisions a future where every young adult living with diabetes has

TO CLAIM TIFFANY'S ALIGNED BREAKTHROUGH EXPERIENCE FOR FREE FOR BACK2BASICS LISTENERS, MESSAGE HER ON HER IG OR FB ACCOUNTS THE WORD: "ALIVE"    https://www.instagram.com/coachtiffanyowenLearn more about Tiffany at: https://coachtiffanyowen.com/https://www.instagram.com/coachtiffanyowenBuy Tiffany's book at: https://a.co/d/3zLsBxqShow Notes:

Purchase The 11.11 Ritual Bundle here.Welcome to The Manifestation Collective Podcast. Are the stories you tell yourself helping you manifest the life you want, or silently sabotaging it?In this episode, we explore:How the stories you tell yourself become your realityWhy your subconscious mind searches for evidence to prove your beliefs rightThe role of the RAS (Reticular Activating System) in manifestationHow repeating limiting beliefs (e.g., “no one is spending money,” “there are no good men”) blocks what you wantThe Daily Evidence Challenge — how to collect proof of your new empowering beliefA personal story about reframing dating beliefs and actively seeking “green flags”How to rewrite your internal narrative using a simple three-step reframe scriptSelf-concept work: shifting from “this is just how I am” to “I get to choose who I become”Real examples of how clients inside The Collective changed their identity and saw resultsJournal prompts to help you rewrite your story and align with your Future SelfIf you loved this episode, take a screenshot, share it on Instagram and tag me at @themanifestationcollective and don't forget to leave a 5-star rating and review.ResourcesJoin The Collective waitlist: www.themanifestationcollective.co/the-collective-membershipDaily Dose of Magic Card Deck: themanifestationcollective.co/product/manifestation-card-deckManifest £10k Months Subliminal Download: themanifestationcollective.co/free-subliminal-sign-up-pageFuture You Guided Visualisation Download: http://www.themanifestationcollective.co/futurePurchase "Manifesting For Beginners": https://bit.ly/3w4EOSN / Purchase "How To Manifest Anything": https://bit.ly/44thTNGVisit my website: themanifestationcollective.coLet's chat on Instagram: instagram.com/themanifestationcollectiveSubscribe to my YouTube Channel: youtube.com/@themanifestationcollectiveFocus: rewrite your story, change your limiting beliefs, subconscious mind manifestation, how to change your self concept, manifestation mindset shifts, RAS manifestation, evidence collecting for new beliefs, how to stop negative self talk, how to change your reality with thoughts, identity shifting, how to reprogram your subconscious beliefs, daily evidence challenge manifestation, how to stop sabotaging your manifestations, how to change your internal narrative, manifestation through self concept Hosted on Acast. See acast.com/privacy for more information.

Hoe zit het nou echt met de rechtszaak van Raisa? Moeten we versterkte gebedsoproepen onbeperkt toestaan? En we spreken de net vrijgesproken Jan Roos. Wanneer ben je een Nederlander? Hoe belangrijk is het hebben van roots in een plek? Ras-echte Fries Rypke Zeilmaker komt het uitleggen.

Have you ever wondered why you keep hitting the same income ceiling no matter how hard you work? What if there’s an invisible number in your brain that’s been controlling your financial reality this entire time? In this groundbreaking episode, we dive deep into the neuroscience of self-worth and discover why your brain has a “financial thermostat” that keeps you stuck at the same level. You don’t need more strategy or hustle—you need to understand the neural programming running in the background and learn how to rewire it. This episode reveals three shiny golden nuggets that will help you transform your financial ceiling into your next breakthrough. The Brain’s Financial Thermostat: Your brain operates with something called homeostasis, the tendency to maintain stable, familiar conditions. Just like your body has a temperature set point, neuroscientists have discovered your brain creates a financial set point based on your early experiences and childhood programming. When you try to exceed this invisible number, your amygdala (the brain’s fear centre) lights up, releases cortisol, and treats financial expansion as a threat. Catherine explains how your nervous system activates “homeostatic correction” to bring you back to the income level it believes keeps you safe—causing you to make impulsive purchases, avoid opportunities, or create crises that demand your money or attention. The stunning part? This set point was installed before you were seven years old. The Inherited Story: Developmental psychology shows that children are in a hypnotic state from birth to age seven, downloading everything through osmosis. You absorbed your family’s relationship with money—the tension when bills arrived, the shame around what you couldn’t afford, the spoken and unspoken messages about who “deserves” wealth. Research in epigenetics reveals that financial stress doesn’t just affect you; it affects your children’s nervous systems. When your parents said “Money doesn’t grow on trees” or “We can’t afford that,” your child’s brain didn’t analyse those statements—it absorbed them as truth, as identity, as the rules of reality. Your nervous system built neural pathways to match your family’s set point. This isn’t about blame, it’s about biology. Your set point isn’t your fault, but it is your responsibility to become aware of it. The Evidence Loop: Your brain doesn’t just have a set point; it actively works to prove that set point is correct through your Reticular Activating System (RAS). This network of neurons filters the 11 million bits of sensory information bombarding you every second, allowing only 40 to 50 bits through to your conscious mind. The catch? It filters based on what you already believe. If your set point says you’re worth $60,000 a year, your RAS will notice evidence that confirms it, ignore opportunities above it, and guide your behavior to maintain it. You’ll undercharge “just this once,” avoid following up on big opportunities, or take time off right when momentum is building. And you’ll have a logical reason for every decision, while underneath, your nervous system is simply doing its job: maintain the set point, stay in the familiar zone, survive. This isn’t just an episode—it’s an invitation to finally see the invisible number that’s been running your financial reality. If you’re ready to interrupt the pattern and raise your set point, this one’s for you. You can watch the video on YouTube. Ready to Raise Your Set Point? Join me for a FREE 90-Minute Masterclass on December 1st If you’re tired of hitting the same income ceiling, knowing you should charge more but something always stops you, this live training will show you exactly which psychological pattern is blocking your breakthrough. You’ll discover: The Revenue Ceiling Diagnostic (3-question framework that reveals YOUR specific block) The 60-second somatic shift that begins rewiring your nervous system for higher income The Confident Pricing Reframe that allows premium entrepreneurs to charge 3-5x more without apology Live breakthrough sessions where I work with volunteers to identify and interrupt their Revenue Ceiling Story in real-time REGISTER FREE – Limited to 50 Seats No replay available for the live breakthrough sessions, so show up if you can.

Dålig sömn – varför det händer och vad du kan göraSömnen – den borde komma naturligt, men för många är den allt annat än självklar. I det här avsnittet pratar vi om vad som händer när sömnen strular, och varför dålig sömn kan få konsekvenser för både kropp, hjärna och vardag.Vi dyker ner i:Vad sömntryck, stress och dygnsrytm har med sömnproblem att göraOlika typer av sömnstörningar: svårt att somna, vakna ofta eller för tidigtHur stresshormoner och problemlösning sent på kvällen kan sabotera insomningenSömnmediciner, melatonin och varför du inte ska vara rädd för att söka hjälpTerapeutiska strategier och varför nedvarvning redan vid åtta på kvällen kan vara avgörandeDu får också konkreta tips på vad du kan göra själv – från att "parkera" tankar på papper, till att skapa god sömnhygien i sovrummet.Oavsett om du själv kämpar med sömnen, eller om någon nära dig gör det, är det här ett avsnitt att ta med sig in i natten.

I used to wake up already behind… planner full, heart racing, brain sprinting. Gold stars on the outside, white-knuckling on the inside. In this episode, we slow the spin. We name the SAFE trap that keeps success at arm's length and we practice the RISE reset so follow through comes from safety, not force.What we do inside:Spot SAFE in the wild: Survival thinking, Avoidance of expansion, Fear-driven choices, Energy leaks from the pastRegulate first so choice comes back onlinePick one truer 10–15% micro-move and let it be enoughEncode it with tapping and a brief hypnotic rehearsal so your body tags it as familiarYou'll tap with me, breathe easier, and rehearse a calmer tomorrow where the next small step actually sticks. Try this after listening: close your eyes, see yourself taking that one micro-move… feel your shoulders drop… then let your RAS collect proof that you can hold it.Want support integrating this work? JOIN THE FREE SKOOL CLASSROOM for resources, and check out the VIP Pattern Reset for EFT rounds, hypnosis tracks, and a private session.Support the showVisit theresalearlevine.org to get Theresa's Book, "Becoming More Me: Tapping into Success - Subconscious Secrets of an ADHD Entrepreneurial Mom" and receive the private sessions for Free!Becoming More Me with Theresa Lear Levine features conversations that Make the Never-Ending Journey of Becoming one you Want to get Present for & Enjoy! Theresa shares her struggles with trauma, anxiety & ADHD, and how nervous system regulation, EFT & Hypnotherapy, took her past her breaking point and into an embodied life of calm, clarity & confidence.Kindle, Audible & Paperback on AmazonCommunity:https://www.skool.com/becoming-more-me-communityBegin your transformation:gamechangingconversation.com Thanks for Listening! Please Leave a Review!Join the Email list:https://theresalearlevine.org/subscribeIG:instagram.com/theresalearlevineEmail:theresa@theresalearlevine.comWebsites:www.theresalearlevine.comwww.becomingmoreme.com...

Show Notes We're heading south of the equator with Miss Bianca and the inimitable Bernard in the Rescuers Down Under. This movie deserves more than it got (thanks Katzenberg). The story of young Cody and his one child crusade against poachers needing the RAS to come help him is beautiful and well told. The big thing that could have made it better was an indigenous protagonist (again, thanks Katzenberg). But Miss Bianca, Bernard the hero, Jake the strapping but kind guide, Wilber, and McCleach are all fantastic and the animation is stunning. RIP every actor in the film, but thank you for your excellent work. Recommendations: Jurassic World: Camp Cretaceous (Netflix) Next up: Beauty and the Beast (1991)   Email us at latecomers@gmail.com Our Facebook group is here for those who consent: https://www.facebook.com/groups/1754020081574479/

Reddit rSlash Storytime r prorevenge where Wronged SO gets revenge on Craig's List I made my ex think his PlayStation had connection issues for calling me names. Have a free drink to wash down your shame. You want to treat my fellow convention-attendee like garbage? OK...there will be consequences. Many years ago, denying a mean girl some bouncy balls when she asked. Fought noise with noise to get loud RAs to close their door Evil Grandmother Mom ignored me asking her not to announce my birthday at restaurants Raccoon troubles. Roommate burned my food, so I matched his energy My boss refused to promote me or give me reasonable raises so I developed skills on the company dime that got me a 100% raise at another company. Take up every seat while waiting 12 minutes for a train? Now you're standing for 45 minutes instead. Old friends f'd me over after I essentially created their buisness Hosted on Acast. See acast.com/privacy for more information.

Discover the secret behind “Why Am I So…” affirmations — the subconscious hack that reprograms your mind to attract money, success, and abundance faster than ever. In this episode, we break down how this simple question flips your brain's filter (RAS) to start noticing wealth opportunities all around you. If you're ready to turn your thoughts into real results, this is the book you don't want to miss.. Learn More. Learn More Affirmation Hacks: https://www.tinyurl.com/MagneticHabits

In this thought-provoking episode of The Six Figure Author Experiment, Russell, Lee, and guest Heather Hildenbrand dive deep into The Science of Scaling — exploring what happens when manifestation meets hustle culture. They debate the book's “tech bro” tone versus its powerful mindset principles and uncover how authors can use identity shifts, nervous system regulation, and space-making to create success sustainably. From millionaire self-concept to burnout recovery, this episode bridges business strategy, psychology, and woo-woo wisdom to redefine what “scaling” really means.Topics Covered:* Why The Science of Scaling feels more like “Manifestation for Tech Bros”* The connection between identity, self-concept, and rapid transformation* Reframing impossible goals as catalysts for identity shifts* Raising your “floor”: creating boundaries and cutting clutter to scale effectively* How nervous system regulation impacts creativity, peace, and success* The biology of manifestation: using the reticular activating system (RAS) intentionally* Healing burnout and reclaiming calm after hustle culture* The power of “creating space” for deep work and emotional health* Why authors must believe they are capable before success can manifest* Delusional goals, embodiment, and future-self meditations* Balancing masculine (strategic) and feminine (energetic) approaches to business* Making peace with uncertainty and doing “dumb” experiments that actually work* Scaling peace of mind versus scaling income* How regulating your body makes scaling sustainable* From survival mode to creative flow: learning to close the stress cycle* Simplifying to scale: finding your “one great idea” instead of chasing everything* Freedom to create vs. freedom from obligation* How to hold your “want” tightly but your “how” loosely* Accepting imperfection: “I'm rich and a hot mess” mindset* Millionaire problems vs. survival problems—and why normalization matters* Manifestation, belief systems, and emotional neutrality as keys to sustainable growth This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.sixfigureauthorexperiment.com

Ever catch yourself predicting the worst - no parks, no luck, no chance - and then proving yourself right? In this refreshingly candid solo episode, Hilary unpacks why so many of us default to spotting the glitch instead of the glimmer - and how a tiny shift in focus can change what you notice, how you feel, and the life you build. Drawing on real-life stories (parking myths, mentoring-room “regrets,” young-Nana trampoline energy, and Toastmasters butterflies) plus bite-sized psychology, Hilary explains negativity bias, the 3-to-1 rule for emotional balance, and learned optimism. You’ll walk away with simple, repeatable practices to re-train your brain’s filter (RAS), flip setbacks into fuel, and start a positive-result spiral on purpose. In this episode you’ll learn: Why the brain overweights bad - and how to rebalance with the 3-to-1 rule. The “Accept or Change” life rule to stop simmering in resentment. How to reframe in real time (from “I have to” → “I get to”). A nightly “Three Glimmers” ritual to rewire your RAS for good. How to surround yourself with glimmer-spotters and visualise the win before it happens. Your Challenge This Week →Each night, list three glimmers - moments, conversations, or coincidences that went right. Then, tomorrow, pick one inevitable hiccup and ask: “What’s the glimmer here?” Bonus points for swapping one “have to” for an “I get to.”

The FiltrateJoel Topf @kidneyboy.bsky.social‬Swapnil Hiremath @hswapnil.medsky.socialNayan Arora captainchloride.bsky.socialSopia Ambruso @sophia-kidney.bsky.socialSpecial Guests Brendon Neuen @brendonneuen.bsky.social Associate Professor and Program Lead, Renal and Metabolic at The George Institute for Global Health. Nephrologist and Director of Kidney Trials at Royal North Shore Hospital.Neuen has had three prior appearances on Freely Filtered: EMPA Kidney, DUPLEX and Sparsentan in FSGS, FLOW and SemaglutideMuthiah Vaduganathan @mvaduganathan on X. Cardiologist at Brigham and Women's Hospital and Harvard Medical School. Assistant Professor of Medicine.Editing byJoel TopfThe Kidney Connection written and performed by Tim YauShow NotesDONATE to NephJC! Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes NEJM | NephJC SummaryFIDELIO Bakris et al, NEJM 2020 | NephJC Summary; subgroup throws doubt on efficacy of finerenone in patients on flozinsFIGARO Pitt et al, NEJM 2021; subgroups clearly shows finerenone works, flozins or notNEJM editorial (wrongly) saying do not use Flozins unless on RASi Don't use dual RAS blockade ONTARGET Yusuf et al, NEJM 2008; VA NEPHRON-D Fried et al NEJM 2013Why we cannot study finerenone in HFrEF (RALES Pitt et al NEJM 1999) Muthu is jealous of GFR slope and albuminuria surrogate endpoints and wants to borrow them for HFpEF (Inker et al EHJ 2025)Combination therapy and CV outcomes in hypertension (Wang et al JAMA Card 2024 on low dose combinations and BP; Egan et al Blood Pressure 2022 review of topic) CONFIRMATION HF trial registry entry (Finerenone and Empagliflozin in hospitalized patients with HF)23:20: Nayan and Swap miss a chance to say ‘de-flozination' to discuss stopping a flozin which would allow a patient to be included in the trial Finerenone is a CYP3A4 substrate (Heinig et al Clin Pharmacokinetics 2023); Useful list of CYP3A4 inducers and inhibitors Everyone should get an ABPM (Bugeja et al CMAJ 2022)EASiKIDNEY study design Albuminuria mediates CKD benefits with Finerenone (Agarwal et al Ann Intern Med 2023)GFR slope and Albuminuria and the FDA (Taylor et al eClin Med 2025) Dapagliflozin and Eplerenone combination crossover trial (Provenzano et al JASN 2022)Joel gets promoted! (PBFluids reflection) Bluesky NephJC Chat discussion on ‘renal remission' Withdrawal of Finerenone and worse outcomes from FINEARTS (Vaduganathan et al JACC 2025)Combination therapies Analysis from Brendan and Muthu (Neuen et al Circulation 2024)Do not use KFRE when GFR > 60 (KDIGO Practice Point 2.2.4: Note that risk prediction equations developed for use in people with CKD G3–G5, may not be valid for use in those with CKD G1–G2) Finerenone vs Spironolactone trial in Primary Aldosteronism (Hu et al Circulation 2025)FIND CKD trial design (Heerspink et al NDT 2025) FINE-ONE trial design (Heerspink et al Diab Res Practice 2023) Tubular SecretionsNayan keeping his chin up as Yankees lose and Mariners follow (MLB Playoffs)Sophia's adventures with Beekeeping (Royal Jelly?) Brendon loves listening to ‘Susan' by Raye Muthu is back into Taekwondo Swap is still reading Martha Wells (Witch King on GoodReads)Joel will be hiking the Laugavegur trail in Iceland

Does niching down mean cutting yourself off from opportunity or is the opposite true and the key to attracting more clients actually lies in how your brain filters reality?In this episode, Jess unpacks the science behind niching down, how your Reticular Activating System (RAS) shapes what you see (and miss) in business, and why your focus, not your effort, determines your success.She bridges the gap between neuroscience and manifestation so you can stop chasing and start magnetising the right clients, opportunities, and results.In This Episode, You'll Learn:Why “speaking to everyone” is the fastest way to stay invisible onlineThe neuroscience of manifestation: how your Default Mode Network, Salience Network, and RAS decide what opportunities you noticeThe energetic and strategic reason niching down expands, not limits, your businessHow to reprogram your subconscious to recognize (and attract) your dream clientsThe “Gorilla Effect”: what your brain literally can't see when your niche and message are unclearHow your marketing frequency mirrors your mindset and how to tune it for client attractionBook Recommendation:Jess mentions Mind Magic: The Neuroscience of Manifestation and How It Changes Everything by James Doty. A powerful look at how science meets spirituality when it comes to rewiring the brain for success and abundance. If you loved today's episode, this read will completely change how you think about your thoughts.NEW! PREMIUM CLIENT ATTRACTION: A three-part on-demand training series designed for women in business who want to attract clients who pay without hesitation and increase their income for the work they're already doing. Enrol here for only $97 with the founding investment (ending soon).

Dirk Arnold und Harald Müller-Huesmann ordnen neue Daten ein: ctDNA-gesteuerte Therapiestrategien, adjuvante und perioperative Immunkonzepte (u. a. ATOMIC, MATTERHORN) sowie Fortschritte bei RAS-gerichteten Therapien im Pankreaskarzinom.

En esta cápsula de ESMO 2025 EXPRESS, el Dr. Mariano Dioca, oncólogo médico adscrito al Instituto de Oncología Ángel H. Roffo en Buenos Aires, Argentina, nos habla sobre las principales novedades en tumores gastrointestinales, destacando cuatro estudiosrelevantes:El estudio PHERFLOT (fase II) evaluó pembrolizumab y trastuzumab en combinación con FLOT frente FLOT en pacientes HER2-positivos con cáncer gástrico o de la unión esofagogástrica. El PERISCOPE II (fase III) analizó la citorreducción peritoneal más HIPEC en cáncer gástrico avanzado, sin demostrar beneficio en supervivencia global.El CITRIC (fase II) exploró el retratamiento con cetuximab + irinotecán frente a terapia estándar (sin inhibidores de EGFR). Finalmente, el PARERE (fase II) comparó las secuencias panitumumab-regorafenib versus regorafenib-panitumumab en el contexto de rechallenge anti-EGFR. 4En conjunto, estos estudios aportan evidencia relevante sobre el papel del rechallenge anti-EGFR y las estrategias inmuno-quimioterápicas en cáncer gástrico y colorrectal avanzado. Referencias:Pembrolizumab and trastuzumab in combination with FLOT in the perioperative treatment of HER2-positive localized esophagogastric adenocarcinoma: Interim analysis of the phase II PHERFLOT/IKF-053 trial of the AIO study group (AIO STO 0321). Abstract # 2095MO, presentado en el marco del Congreso Anual de la Sociedad Europea de Oncología Médica (ESMO®) 2025, celebrado del 17 al 21 de octubre de 2025 en Berlín, Alemania.Systemic therapy, gastrectomy and CRS/HIPEC vs systemic therapy alone for gastric cancer with limited peritoneal dissemination: Results of the randomised PERISCOPE II trial. Abstract #2096MO, presentado en el marco del Congreso Anual de la Sociedad Europea de Oncología Médica (ESMO®) 2025, celebrado del 17 al 21 de octubre de 2025 en Berlín, Alemania.Circulating tumor (ct) DNA-guided anti-EGFR rechallenge strategy in metastatic colorectal cancer (mCRC): Final results of the phase II randomized CITRIC trial. Abstract #LBA33, presentado en el marco del Congreso Anual de la Sociedad Europea de Oncología Médica (ESMO®) 2025, celebrado del 17 al 21 de octubre de 2025 en Berlín, Alemania.Panitumumab retreatment followed by regorafenib versus the reverse sequence in chemorefractory metastatic colorectal cancer patients with RAS and BRAF wild-type circulating tumor DNA (ctDNA): Final results of the randomized PARERE trial by GONO. Abstract #LBA32, presentado en el marco del Congreso Anual de la Sociedad Europea de Oncología Médica (ESMO®) 2025, celebrado del 17 al 21 de octubre de 2025 en Berlín, Alemania.Fecha de grabación: 18 de octubre de 2025 Material exclusivo para profesionales de la salud. Estematerial ha sido desarrollado únicamente con fines educativos e informativos y no tiene la intención de sustituir el juicio clínico de los profesionales de la salud. Las opiniones y declaraciones presentadas en este contenido son responsabilidad exclusiva de los ponentes y no reflejan necesariamente la postura institucional de ScienceLink ni de terceros mencionados. La información presentada se basa en el conocimiento y la experiencia profesional de los ponentes. La veracidad, exactitud y actualidad científica de los datos son de su exclusiva responsabilidad. Así mismo garantizan que el contenido utilizado no infringe derechos de autor de terceros y asumen toda responsabilidad por su uso. Se deberán de revisar las indicaciones aprobadas en el país con estricto apego al marco regulatorio aplicable para cada uno de los tratamientos y medicamentos comentados.  ESMO® es una marca registrada de la European Society ForMedical Oncology. Este material ha sido producido de manera independiente y no está autorizado, patrocinado ni avalado por dicha organización.

Je social media manažér len „ten /tá, čo pridáva príspevky na Facebook“? Vo výživnom rozhovore sme praskli veľa bublín o práci v marketingu, komunite a o tom, ako sa mení svet sociálnych sietí pod vplyvom umelej inteligencie. Dozviete sa, prečo sa neoplatí „omlaďovať publikum“, ako vyzerá ideálny brief, prečo by zakladatelia e-shopov mali tvoriť obsah osobne a ako sa dá organický dosah prepojiť s UGC či humorom. Nechýbajú ani tipy na najlepšie profily, ktoré sa oplatí sledovať, a pohľad do budúcnosti práce social media manažéra, ktorého pozícia je oveľa strategickejšia, než sa na prvý pohľad zdá. Viac informácií nám poskytol Rasťo Kiavčin, founder Digitálci.

It's time for our next installment of the Mommie Dearest series and today we are talking about the 8 Passengers family vloggers. In 2022 the arrest of mom-fluencer Ruby Franke and infamous psychologist Jodie Hildebrandt revealed a shocking case of severe child abuse behind the scenes for one of YouTube's most beloved families. We cover the origins for the 8 Passengers YouTube channel, why it became so successful, the 2020 cancellation, Jodie Hildebrandt's manipulation and Ruby's slippery slope of religious psychosis. Please check the content warnings!Keep your children off the internet and most importantly - let me know what you think!Instagram - @moodforfeud TikTok - @moodforfeud Support the show on Ko-fi all funds go towards upgrading my podcast gear!CW: child abuse, child neglect, torture, religious psychosis, mental unwellnessIntro/Outro MusicYarWritten by Ryan SkeltonProduced by Ras & Sakunera#8passengers #rubyfranke #jodiehildebrandt #familyvlogging

 Explore how Lucky Girl Syndrome and manifestation connect to the neuroscience of the brain's reticular activating system (RAS), and how to use it in IVF without falling into toxic positivity.

In this episode, we are joined by Sarah A. Browne Bradwisch, PhD, RN and Erin Murphy-Smith, MSN, RN to explore the multifaceted implications of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), which are widely used for weight management in addition to diabetes treatment. The conversation reviews the pharmacodynamic and physiologic mechanisms of GLP-1 RAs and addresses the clinical, societal, and psychological dimensions of these medications. The speakers emphasize the nurse's role in patient education, the importance of a thorough health history, and the ethical concerns surrounding both the growing trend of online prescriptions without proper health assessments and use of GLP-1 RAs by adolescents. A key takeaway is the need for holistic care—including psychological support—to ensure that weight loss interventions do not lead to unintended harm. Read the related article, “The physiologic and psychologic effects of glucagon-like peptide-1 receptor agonists” in the September issue of Nursing2025. Transcript

If you feel like you've been doing everything right but still not seeing progress in fitness, mindset, or life... This episode will hit hard.In today's episode of The SupaFit Couple Podcast, we're breaking down the real reason you're still stuck… and the truth that most people avoid hearing: no one's coming to save you. We go over the top 3 traits you need to be successful based on our top performing clients.You'll learn how to:• Stop waiting for motivation and start taking control of your life• Let go of ego and actually ask for help when you need it• Use your mind's focus system (RAS) to start seeing opportunity everywhere• Build the discipline and belief that create real change in fitness, relationships, and mindset.The hard truth: your life won't change by luck, it changes when you do. APPLY FOR 1:1 ONLINE FITNESS COACHING:https://forms.gle/DRYakCyYa7T3SYsb9_________Let's Connect:Youtube | @SupaCoopaInstagram | @SupacoopaaaTiktok | @Supacoopaaa

Decision fatigue and role confusion often show up in the body first. If growth feels unsafe or expansion feels overwhelming, this episode explains how recalibration retrains your nervous system to embrace alignment instead of fear.Why does growth feel unsafe even when you know it's right? For many high-capacity humans, the barrier to expansion isn't strategy or skill — it's the nervous system itself.In this episode of The Recalibration, Julie Holly unpacks why the body often resists aligned growth. Neuroscience explains it through predictive processing and the reticular activating system (RAS) — the brain prefers what it can predict, even if it's unfulfilling. That's why new opportunities trigger anxiety, decision fatigue, and self-protection.Through personal stories of endurance cycling and the challenges of marriage, Julie shows how resistance reveals deeper scripts like Prover or Performer. And through the story of Brian Chesky, cofounder of Airbnb, you'll see how expansion that once felt unsafe can become the pathway to global transformation.Here's where Identity-Level Recalibration (ILR) shifts everything. Your nervous system is wired for survival, not alignment. ILR re-patterns this response, teaching your body that newness doesn't equal danger — it equals alignment. Unlike mindset tactics or productivity hacks, ILR is the root-level recalibration that makes every other tool effective.If success feels empty, if you're exhausted by performance pressure, or if you've been resisting growth because it “feels risky,” this episode will help you see what's really happening — and how to lead yourself and others into expansion that lasts.Today's Micro Recalibration:Where is my body confusing risk with danger?How can I reassure it that growth is safe?As a leader, how might I help my team reframe risk as alignment?If this episode gave you language you've been missing, please rate and review the show so more high-capacity humans can find it. Explore Identity-Level Recalibration→ Follow Julie Holly on LinkedIn for more recalibration insights → Schedule a conversation with Julie to see if The Recalibration is a fit for you → Download the Misalignment Audit → Subscribe to the weekly newsletter → Join the waitlist for the next Recalibration cohort This isn't therapy. This isn't coaching. This is identity recalibration — and it changes everything.

So much of your food and body battle comes down to one thing: belief. The women who finally break free from diet culture aren't the ones with more willpower — they're the ones who learn to change the beliefs holding them back. In episode 260 of Fitness & Sushi, I'm going to show you why the beliefs you hold about yourself are the true drivers of your choices, and how to finally break free from the stories diet culture has planted in your mind. In this episode – “How to Break Free From Limiting Beliefs About Food, Your Body, and Exercise” – you'll learn…

Discover the “50 Ways” exercise that sparks creativity, expands opportunities, and helps you manifest more in business and life.Feeling stuck, uninspired, or limited in your options? In this episode of Biz Besties, Nicole and Kaila share their favorite tool to break through creative blocks: the “50 Ways” method.This simple but powerful exercise helps you brainstorm beyond limits, tap into your reticular activating system (RAS), and notice opportunities you may have been missing. From making more money to growing your audience or even finding your next big idea, this practice will expand your sense of possibility.You'll also hear how this exercise helped Nicole and Kaila expand into the US market—leading to aligned connections, new clients, and unexpected manifestations.Tune in and try it for yourself—you'll be surprised at what unfolds after idea number 25!Key TakeawaysThe 50 Ways Hack – Why forcing yourself to write down 50 ideas (even the silly ones) opens the door to creativity, new opportunities, and unexpected breakthroughs.Mindset + Environment Matter – How setting aside quiet space, using tools like binaural beats, and removing distractions helps you get into your creative “zone.”Manifestation in Action – Real-life examples of how this practice led to expanded opportunities, new clients, and even chance encounters that aligned with bigger goals.Want to magnetize more wealth and abundance? Grab our Frequency of Wealth Bundle here: https://www.myalignedpurpose.com/fow

Toni Sant presents the 740th in a series of podcasts featuring music by performers in or from Malta. Artists featured in this podcast: PART 1Vinyl Paradise - Sold My SoulKill the Action feat. Moira Stafrace - The FallRAS - FrustrazzjoniKylo - My FriendKayati - Tell Your MamaBanjo Lucia - Hold on TightIl-Majca feat. Kiita-C - Kollox SpiccaPART 2Bee - unlikely (EP)Featured album: Tiny Keys Big Sound ta' Tricia Dawn Williams >> Details about this podcast [in Maltese] See also: - MMI Podcast: YouTube playlist - MMI Podcast: Facebook Page - MMI Archive on Mixcloud | @tonisant on Twitter - M3P: Malta Music Memory Project - Mużika Mod Ieħor ma' Toni Sant on Facebook (MP3)

Review các phim ra rạp từ ngày 26/09/25ĐỒI HÀNH XÁC – T18Đạo diễn: Lương Đình DũngDiễn viên: Hứa Vĩ Văn, Nguyễn Xuân Thắng,Thể loại: Hồi hộp, Kinh DịBảo là một chàng trai trẻ làm nghề sửa xe và đồng thời sở hữu một ga-ra xe hơi cũ. Khi tháo dỡ một chiếc xe từ thập niên 90, Bảo vô tình đánh thức một thế lực tà ác, kéo theo hàng loạt sự kiện kỳ dị xảy đến với anh và những người xung quanh. Cùng với sự có mặt của một điều tra viên bí ẩn (Hứa Vĩ Văn), bí mật từ quá khứ đội mồ sống dậy, bóc trần những góc khuất của lòng tham và sự tàn bạo nơi con người.EXIT 8: GA TÀU VÔ TẬN – T16Đạo diễn: Genki KawamuraDiễn viên: Kazunari Ninomiya, Yamato Kochi, Thể loại: Kinh DịBộ phim xoay quanh một chàng trai trẻ bị mắc kẹt trong một hành lang tàu điện ngầm vô tận và lạnh lẽo. Tại đây, anh chàng bất đắc dĩ phải tham gia vào một trò chơi tìm kiếm “lối ra số 8”. Vòng đầu tiên sẽ bắt đầu từ “lối ra số 0”, luật chơi tưởng chừng rất đơn giản: Đừng bỏ qua bất kỳ điều gì bất thường ở hành lang của mỗi lối ra. Nếu phát hiện điều gì sai, hãy lập tức quay đầu. Nếu không thấy gì thay đổi, cứ đi tiếp. Nhưng chỉ một lần lơ là, người chơi lập tức trở về điểm xuất phát. Giữa mê cung vô tận với những cơn ảo giác ập đến, liệu anh chàng có thể giành chiến thắng và trở về với thực tại?TRẬN CHIẾN SAU TRẬN CHIẾN – T18Đạo diễn: Paul Thomas AndersonDiễn viên: Leonardo DiCaprio, Sean Penn, Benicio Del Toro, ..Thể loại: Hành Động, Hồi hộp, Tâm LýBob Ferguson (Leonardo DiCaprio) và vợ từng là thành viên của một tổ chức cách mạng mang tên French 75. Nhiều năm sau, một sự kiện bất ngờ xảy ra khi cô con gái tuổi teen của cả 2, Willa (Chase Infiniti) bất ngờ bị bắt cóc. Để giúp Bob tìm lại con gái, những nhà cách mạng trong tổ chức đã cùng hợp tác với nhau một lần nữa. Trên hành trình tìm kiếm Willa, Bob cùng những đồng đội của mình không chỉ giáp mặt những kẻ thù cũ mà còn chứng kiến những bí mật từ quá khứ lần lượt bước ra ánh sáng.Xác Chết Về Quê – T16Đạo diễn:Adriano RudimanDiễn viên:Aghniny Haque, Thể loại:Kinh dịRas và Yudhis chỉ muốn chôn vùi nỗi đau buồn của họ - Nhưng thi thể của cha họ đã trỗi dậy và bước đi. Điều gì thực sự còn dang dở?CHAINSAW MAN - THE MOVIE: CHƯƠNG REZE – T18Đạo diễn: Tatsuya YoshiharaDiễn viên: Kikunosuke Toya, Thể loại: Hành Động, Hoạt Hình, Thần thoạiỞ phần trước, ta đã biết Denji từng làm Thợ Săn Quỷ cho yakuza để trả món nợ của cha mẹ nhưng bị họ phản bội và trừ khử. Trong khoảnh khắc hấp hối, chú chó quỷ cưa máy Pochita (người bạn đồng hành trung thành của Denji) đã đưa ra một khế ước, cứu sống cậu và hợp thể cùng cậu. Từ đó, một Quỷ Cưa bất khả chiến bại ra đời. Giờ đây ở Chainsaw Man – The Movie: Chương Reze, trong cuộc chiến tàn khốc giữa quỷ dữ, thợ săn quỷ và những kẻ thù trong bóng tối, một cô gái bí ẩn tên Reze xuất hiện trong thế giới của Denji. Denji buộc phải đối mặt với trận chiến sinh tử khốc liệt nhất của mình, một trận chiến được tiếp sức bởi tình yêu trong một thế giới nơi mọi người phải sinh tồn mà không biết bất kỳ luật lệ nào.NHÀ BÚP BÊ CỦA GABBY: PHIM ĐIỆN ẢNHĐạo diễn: Ryan CregoDiễn viên: Laila Lockhart Kraner, Kristen Wiig,...Thể loại: Hoạt Hình, Phiêu LưuBộ phim xoay quanh câu chuyện Gabby cùng bà ngoại Gigi lên đường đến xứ sở thần tiên đô thị Cat Francisco. Nhưng khi ngôi nhà búp bê của Gabby, vật sở hữu quý giá nhất của cô, rơi vào tay một bà mèo lập dị tên Vera, Gabby bắt đầu cuộc phiêu lưu vào thế giới thực để đoàn tụ với những chú mèo Gabby và cứu ngôi nhà búp bê trước khi quá muộn.BTS 2016 LIVE THE MOST BEAUTIFUL MOMENT IN LIFE ON STAGE: EPILOGUE REMASTEREDĐạo diễn: Jo HyeongseokThể loại: Hòa nhạc, Phim tài liệuTrở lại với hồi kết huy hoàng của series “The Most Beautiful Moment in Life” – nơi tuổi trẻ rực rỡ nhất được khắc họa qua âm nhạc và sân khấu của BTS.-------------------------------------------#8saigon #reviewphimrap #doihanhxac #exit8gatauvotan #tranchiensauttranchien

How to achieve your Dreams and Goals Want real results — not hype? In this episode of Personal Development Unplugged Paul Clough shows you how to move from wishful thinking to action that works. We dig into practical goal-setting, the feeling of the wish fulfilled, how to use your mind (RAS + visualization), and small, actionable steps that create momentum. Expect NLP-informed tips, a short guided hypnosis process to embed success in your unconscious, and direct coaching you can use today. Key takeaways Define success specifically: the clearer the goal, the faster the result. Use feeling of the wish fulfilled + physiology + inner dialogue to “act as if.” Employ the Reticular Activating System—focus your mind and notice opportunities. Build micro-steps (tiny wins) and schedule regular reviews to stay on track. Align goals with your values — ensure they're ecological (good for you, others, planet). Quick practical guided hypnosis included — make this a daily habit. Share with one person who needs permission to step up today. Have more fun than you can stand. https://personaldevelopmentunplugged.com/463-how-to-achieve-your-dreams-and-goals Shine Brightly

Argumenterar för ett färgblint samhälle i ny bok. Lyssna på alla avsnitt i Sveriges Radio Play. I USA har president Trump tagit upp kampen mot vad han anser är splittrande idéer som slagit klorna i kulturlivet. Och även om man kan ha synpunkter på hans metoder så har han i grunden rätt - det menar författaren och debattören Coleman Hughes, aktuell med boken "Färgblind - en strävan bortom raspolitik". P1 Kulturs Mårten Arndtzén har träffat honom på besök i Stockholm.

Understanding Focus: The RAS Have you ever noticed that once you buy a new car, suddenly that model seems to be everywhere? Or you hear a new word and then it pops up all the time? That's not magic – it's your Reticular Activating System (RAS) at work. In this Five Minute Quickie, I'm breaking down the RAS in plain English. It's the part of your brain that decides what to notice – and it's powered by emotion. The good news? You can train it to look for opportunities, positivity, and success. The bad news? If you're stuck in negative emotions, it will keep showing you reasons to stay stuck. So let's flip the switch. Learn how to focus on what serves you rather than what drags you down. Because when you understand your RAS, you can use it to fuel your goals, dreams, and everyday happiness.  And keep listening – in the next longer episode I'll guide you through a process (with a bit of hypnosis) to help your unconscious mind focus deeply on what you truly want. You could start by focusing on sharing. Here is a link to this episode https://personaldevelopmentunplugged.com/fmq-514-understanding-focus-the-ras Shine Brightly

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-451 Overview: The obesity epidemic has fueled a demand for weight loss medications. Trials have directly compared medications—specifically glucagon-like peptide-1 receptor agonists (GLP-1 RAs)—with a recent study doing just that. Tune in as we explore the evidence comparing semaglutide and tirzepatide for weight loss outcomes up to 1 year. Episode resource links: Rodriguez PJ, Goodwin Cartwright BM, Gratzl S, et al. Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity. JAMA Intern Med. 2024;184(9):1056-1064.  Moiz A, Filion KB, Toutounchi H, et al. Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss Among Adults Without Diabetes : A Systematic Review of Randomized Controlled Trials. Ann Intern Med. 2025;178(2):199-217.  Wen J, Syed B, Nadora D, et al. Tirzepatide Versus Semaglutide on Weight Loss in Type 2 Diabetes Patients: A Systematic Review and Meta-Analysis of Direct Comparative Studies. Endocrinol Diabetes Metab. 2025;8(3):e70045.  Guest: Alan M. Ehrlich, MD, FAAFP Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com  

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-451 Overview: The obesity epidemic has fueled a demand for weight loss medications. Trials have directly compared medications—specifically glucagon-like peptide-1 receptor agonists (GLP-1 RAs)—with a recent study doing just that. Tune in as we explore the evidence comparing semaglutide and tirzepatide for weight loss outcomes up to 1 year. Episode resource links: Rodriguez PJ, Goodwin Cartwright BM, Gratzl S, et al. Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity. JAMA Intern Med. 2024;184(9):1056-1064.  Moiz A, Filion KB, Toutounchi H, et al. Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss Among Adults Without Diabetes : A Systematic Review of Randomized Controlled Trials. Ann Intern Med. 2025;178(2):199-217.  Wen J, Syed B, Nadora D, et al. Tirzepatide Versus Semaglutide on Weight Loss in Type 2 Diabetes Patients: A Systematic Review and Meta-Analysis of Direct Comparative Studies. Endocrinol Diabetes Metab. 2025;8(3):e70045.  Guest: Alan M. Ehrlich, MD, FAAFP Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com  

Viete, čo máme úplne všetci spoločné pri narodení a hneď od začiatku nám to je prirodzené tak ako dýchanie? Kreativita. Dospelí vidia zlomený suchý konár, deti vidia čarovný prútik. My vidíme obyčajný kameň, no tí najmenší vidia vzácny drahokam. Kedy a prečo sa z nás kreativita vytráca? Vplyv na to majú aj dospeláci, s ktorými sme boli v kontakte počas nášho detstva. Existujú však ľudia, ktorí v nás dokážu opäť zapáliť oheň kreativity. Jeden z nich je aj kreatívec a sprievodca vedomou kreativitou Rasťo Michalík.

Retirement is often envisioned as the reward at the end of a long career, but too many people find themselves adrift once finances are settled, lacking a sense of purpose and fulfillment. Cyn Meyer, author of "The Rewire Retirement Method: Ailing from Aimless to Amazing," and founder of Second Wind Movement, offers a transformative approach to redefining retirement—one built not on financial spreadsheets, but on neuroscience, clarity, and sustained personal growth.From Aimless to Amazing: Redefining RetirementTraditional retirement planning focuses almost exclusively on money—401ks, nest eggs, and the dream of untethered leisure—but the real challenge is psychological and emotional. Meyer's experience as a life coach for retirees, combined with personal family events and a background in neuroscience, led her to create a system that unlocks genuine fulfillment after career ends. She saw firsthand retirees with substantial assets fall into a "retirement rut": losing momentum, purpose, and zest for living, which often gives way to anxiety, depression, and a sedentary lifestyle.The Rewire Retirement SystemMeyer's method, built into a three-month program and distilled in her book, centers around clarity before action. Instead of rushing to fill time with stereotypical pursuits like pickleball or beach days, her system guides individuals to uncover their authentic identity for this new phase. The process leverages neuroscience, notably the reticular activating system (RAS), prodding the brain daily toward new, meaningful pathways that fuel purpose.The method breaks retirement into "Five Rings," each representing a part of this holistic journey:Giving Back: Community involvement, volunteering, sharing wisdom.Recreation: Physical, creative, and leisure pursuits.Connection: Building deeper relationships and family ties.Personal Growth: Learning new skills, overcoming challenges.Legacy: Creating impact and meaning, be it through family, professional boards, or artistic expression.Rather than an all-at-once overhaul, the program recommends microsteps—small, daily actions (about 20 minutes a day)—to incrementally build a life that is both unique and deeply satisfying. The approach emphasizes that retirement is a launchpad for upward growth, not a period of descent or withdrawal.Real Success and ResilienceThe outcomes of Meyer's approach are as unique as the individuals who use it. Some find renewed drive—like the client who, after severe health setbacks and mini-strokes, used the microstepping system to reconnect with family, grow stronger physically, and hike mountains by age 70. Others discover latent passions, such as joining professional boards, writing books, or grandparenting with deeper relationships.Importantly, Meyer notes that the age at which someone begins this journey is irrelevant—what matters is the internal search for what's missing. Everyone is vulnerable to feeling "rudderless" if purpose is lacking, regardless of physical health or previous achievements. Her message is clear: when that subtle void appears, it's time to act.Individuality Over ComparisonOne vital lesson Meyer shares is to resist comparing retirement journeys. Each person is an individual, with unique dreams, goals, and intrinsic motivators. The path in this new chapter should be drawn inwardly, not by keeping up with the societal or financial benchmarks of others.Getting Started: Tools and AccessFor those interested, Meyer offers entry points through her website, SecondWindMovement.com, which includes a free masterclass and courses such as the 14-day Purpose Jumpstart. Her book is available for deeper self-guided exploration. The goal is accessibility for anyone, not just those who can afford private coaching.

Med ett förändrat klimat väntas fler ras och skred som de som nu skett i Ångermanland. Men det går att förebygga dem. Lyssna på alla avsnitt i Sveriges Radio Play. Efter de senaste skyfallen i Västernorrland står många kvar i chock – vägar har spolats bort, samhällen har isolerats, och en människa har tragiskt nog mist livet. Nu pekar experterna på att det här förmodligen inte är ett engångsfenomen. Med klimatförändringarna väntas ras, skred och översvämningar bli både fler och dyrare att röja upp efter. Men det finns hopp – rätt insatser i tid kan skydda både människor, bostäder och landskap. I det här programmet möter du experterna som har räknat på riskerna och som vet vad som behöver göras. Medverkande: HannaSofie Pedersen, chef för strategisk klimatanpassning på Statens Geotekniska Institut, som identifierat riskområden för ras och skred och analyserat hur mycket vanligare de kan bli fram över. Sandra Fyrstedt, gruppchef inom prognos- och varningstjänsten på SMHI, och Fredrik Birging på P4 Västernorrland, som varit på de drabbade platserna i veckan.Producent: Sara Sällströmsara.sallstrom@sverigesradio.seProgramledare: Camilla Widebeckcamilla.widebeck@sverigesradio.se

Do najnovšej epizódy hokejového podcastu suSPEAK na ŠPORT.sk si moderátori Marek Marušiak a Rasťo Konečný pozvali muža, ktorý stojí za letnou prípravou našich elitných hokejistov na ľade. Matej Múčka, korčuliarsky špecialista a tréner, ktorý spolupracuje s hráčmi ako Tomáš Tatar či Pavol Regenda, otvorene porozprával o svojej ceste od aktívneho hokejistu k uznávanému trénerovi.Bývalý hráč Slovana a mládežnícky reprezentant Matej Múčka odhalil, ako ho zranenia prinútili prehodnotiť kariéru a ako sa napokon našiel v trénerskej profesii. „Začínal som v Česku na trénerských kempoch, kde ma prekvapilo, že deti mali dva tréningy denne a na oboch ani nevideli puk,” spomínal na svoje trénerské začiatky v Karlových Varoch, kde spoznal úplne iný prístup k hokejovej príprave.V rozhovore spoznáte aj pikantné detaily z tréningov hviezdnych profíkov, ktorí sa pod jeho vedením pripravujú v lete. „Martin Fehérváry príde a ihneď prvé, čo povie: ‚Dobre, o 5 eur!' Pavol Regenda zas miluje súťaže a doťahovačky,” usmieva sa pri spomienke na súťaživosť profesionálov, ktorí si neodpustia ani tie najmenšie stávky.Nezabudnuteľné sú spomienky Mateja Múčku na MS v hokeji do 18 rokov v Rusku, kde bol súčasťou generácie s Marekom Viedenským či Martinom Štajnochom. „Išli sme do oslabenia, vyhodili sme puk, Rišo Pánik uletel a gól na 1:0. To bola eufória!” zaspomínal si na zápas proti Rusku.Ešte väčší priestor venoval historke o trénerovi Milanovi Stašovi, ktorý na letisku nabíjal svoj telefón cez zásuvku pri obrovskom vianočnom stromčeku a spôsobil výpadok elektriny.Matej Múčka otvorene rozprával aj o svojej trénerskej filozofii. „Chcem byť pre deti autorita, ale aj kamarát a vzor. Snažím sa im ukázať každý cvik, aby videli, že sa to dá,” vysvetľuje s tým, že ho teší, keď u svojich zverencov vidí progres. Jeho ambíciou je posunúť sa do profi hokeja a pracovať aj s reprezentáciou.V zábavnej a inšpiratívnej najnovšej epizóde podcastu suSPEAK na ŠPORT.sk sa dozviete veľa nielen o hokejových zručnostiach, ale aj o tom, ako skúsenosť z I. ligy v Topoľčanoch, kde praváci hrali III. tretinu s ľavačkami, formovala cestu Mateja Múčku k vrcholovému trénerskému remeslu.

Nyheter och fördjupning från Sverige och världen. Lyssna på alla avsnitt i Sveriges Radio Play.

Ras Vanderloo recently retired after his 14th season as the Head Boys Basketball Coach at Sioux City East High School in Sioux City, IA. He spent 32 years coaching basketball, 14 as a Head Coach and 18 as an Assistant Coach. Ras is a 5-time district coach of the year and the 2017 State 4A Coach of the Year. He won 314 games as a head coach at East High with 4 State Tournament appearances and a State Runner Up in 2012.In addition to his run as the Head Coach at East, Ras also runs a large youth league basketball program with over 650 kids annually participating. The league is currently 33 years old and was started by his father.Ras comes from a large coaching family, his father Rich and brother Jeff (now a Creighton Assistant) are both former Head Coaches at East High in Sioux City. His brothers John and Jim are coaches as wellRas has worked with USA Basketball in varying capacities, most recently as an assistant coach for the Men's 3 x 3 Nation's League that competed this summer in Chile. On this episode Mike & Ras discuss his retirement from teaching and coaching along with the new opportunities in front of him, including his involvement with USA Basketball. Vanderloo reflects on the significance of learning from experienced mentors and emphasizes the value of dedication and hard work in achieving success in coaching. He shares insights about the differences between coaching in traditional formats versus the increasingly popular 3x3 basketball format, highlighting the unique challenges and strategies involved in this fast-paced version of the game. Additionally, Vanderloo provides practical advice for young coaches, advocating for the importance of seeking out successful programs and experienced coaches to learn from. As he navigates his post-retirement journey, he remains committed to contributing to the basketball community and mentoring future generations of coaches.Follow us on Twitter and Instagram @hoopheadspod for the latest updates on episodes, guests, and events from the Hoop Heads Pod.Make sure you're subscribed to the Hoop Heads Pod on your favorite podcast app and while you're there please leave us a 5 star rating and review. Your ratings help your friends and coaching colleagues find the show. If you really love what you're hearing recommend the Hoop Heads Pod to someone and get them to join you as a part of Hoop Heads Nation.Get ready to take some notes as you listen to this episode with Ras Vanderloo from Sioux City East High School in the state of Iowa.Website – https://www.usab.com/staff-members/ras-vanderlooEmail – rvanderloo6562@gmail.comTwitter - @CoachRasVisit our Sponsors!Dr. Dish BasketballOur friends at Dr. Dish Basketball are here to help you transform your team's training this off-season with exclusive offers of up to $4,000 OFF their Rebel+, All-Star+, and CT+ shooting machines. Unsure about budget? Dr. Dish offers schools-only Buy Now, Pay Later payment plans to make getting new equipment easier than ever.The Coaching PortfolioYour first impression is everything...

Welcome to the The Achievers Podcast.  I'm your host, Amber Deibert, Performance Coach. I help enterprise sellers unlock their full potential by aligning their work with how they work and cleaning up mindset trash, so they can sell more, stress less, and take back control of their time and success. Do you cringe when someone asks, “Where do you see yourself in five years?” Most achievers love the idea of having a plan but freeze up trying to make one. In this episode, Amber walks you through a simple, values-based process to design a 5- and 10-year plan you'll actually stick with. No overwhelm, no overthinking… just clarity, direction, and next steps.  

Sarah Biskowitz and Ruby Zuckerman joined "The Shmooze" to talk about the Great Jewish Books Summer Program. Sarah and Ruby, alums of the program, are back at the Yiddish Book Center as RAs for this year's program. In conversation we talk about their experiences as participants and as RAs and learn about how Great Jewish Books lead them in new directions, personal and professional. And we hear what's on the reading list for this summer's students. Episode 395 August 7, 2025 Amherst, MA

How can we prevent our older adults with prediabetes from developing diabetes?  Susan is a board certified health and wellness coach.  She is a certified with the CDC diabetes prevention program and owner of Weighting4You.  She will walk us through the use of continuous glucose monitors (CGMs) to assist with lowering HgbA1c, counseling tips for patients on GLP-1 RAs, and more.  I hope you enjoy our conversation.   The Geriatric Pharmacy Focus podcast is for general informational purposes only and does not constitute the practice of medicine, nursing or other professional health care services, including the giving of medical advice, and no doctor/patient relationship is formed. The use of information on this podcast or materials linked from this podcast is at the user's own risk. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice for any medical condition they may have and should seek the assistance of their health care professionals for any such conditions. Connect with Tamara here:  www.linkedin.com/in/tamara-ruggles-491882251 www.thedeprescribingclinic.com Connect with Susan here:linkedin.com/in/susanward https://weighting4you.com/

Grandpa Bill Asks: listeners, picture this: We're standing with Dr. Metivier inside the early structure of his physical Memory Palace in Australia. Sunlight streams through the unglazed windows, illuminating the concrete floor where the A-to-Z memory wheel will soon be. In the center of this space, Dr. Metivier stands with his real bass guitar.Now, let's use the Major System to create a memorable scene of him playing multiple Bach works, associating each number with a specific action or element related to a piece.0 - S/Z/Soft C: Imagine Dr. Metivier zipping up a black leather jacket as he prepares to play the opening of Bach's Toccata and Fugue in D minor (often adapted for bass). The 'zipping' sound and the dramatic nature of the piece connect to the 'S' sound of zero.1 - T/Th: He then begins the famous Air on the G String from Orchestral Suite No. 3. Imagine him gently tapping his foot in time with the melody. The 'T' sound links to the number one and the flowing, gentle nature of the piece.2 - N: Next, he transitions to a lively section from one of the Brandenburg Concertos. Visualize a flock of gnats buzzing around his head as he plays a particularly intricate and fast passage, representing the quick, busy nature of the music. The 'N' sound connects to the number two.3 - M: For the powerful Passacaglia and Fugue in C minor, imagine a giant ham swinging rhythmically in front of him as he plays the deep, grounding bass line of the Passacaglia. The 'M' sound links to three, and the weighty image reflects the music's gravitas.4 - R: As he moves to a movement from one of the Cello Suites, picture a rower in a small boat gently rocking back and forth in time with the bowing motions his right hand makes on the bass strings. The 'R' sound connects to four and evokes the smooth, flowing quality of the cello.5 - L: Imagine a bright light suddenly illuminating the fretboard as he plays a particularly beautiful and soaring melodic line from the Mass in B minor (again, a bass adaptation). The 'L' sound connects to five and emphasizes the radiant quality of the music.6 - J/Sh/Ch/Soft G: For an adaptation of one of the English Suites, see him suddenly wearing a chef's hat and playfully conducting with his head while he plays a more dance-like and rhythmic section. The 'Ch' sound connects to six and adds a whimsical element.8 - F/V: As he plays a section from the Goldberg Variations (arranged for bass), imagine fluffy white foam suddenly erupting from the sound holes in his bass, bubbling and dissipating with the intricate variations. The 'F' sound connects to eight and provides a visual texture to the complex music.9 - P/B: Finally, for a powerful cadence, imagine a large purple balloon inflating and then gently deflating in time with the final, resonant notes of a Bach Chorale. The 'P/B' sounds connect to nine and provide a strong visual conclusion.So, there you have it, Dr. Metivier in his future Memory Palace, playing a medley of Bach, with each piece and a corresponding Major System number brought to life through a vivid mnemonic image. This is the power of the Magnetic Memory Method in action, connecting sound, image, and location in a truly unforgettable way. Dr. Metivier will be on my Podcast on 8/12/25 WE will discuss his thoughts on this at that time stay tuned!#BachOnBass,#MajorSystem,#MnemonicMusic,#PhysicalMemoryPalace,#Dr.AnthonyMetivier#MagneticMemoryMethod,#Bach,#MemoryPalace,#GrandpaBill,#BHSalesKennelKelpHolisticHealingHour,Join us at The BH Sales Kennel Kelp Holistic Healing Hour Podcast Daily and YouTube @billholt8792

10 - Imam Sadi's explanation of Jawaami' Al-Akhbaar | Abu Abdir-Rahmān Hilāl - Manchester Explanation of Shaykh Ubayd al-jaabiree Abū Hurayrah (raḍī Allāhu ʿanhu) said: Rasūlullah (ﷺ) said: Allāh does not accept the Prayer of anyone of you who has nullified his purification until he makes wuḍū. Narrated by Bukhari & Muslim Live at the Salafi Centre of Manchester on 2/8/25

Feeling stuck in the manifestation gap — that frustrating space where your desires haven't arrived yet? In this episode, we're diving into why the delay doesn't mean it's not working, how to shift your mindset when you start to doubt, and what your brain is doing behind the scenes to filter your reality.You'll learn:Why the absence of evidence isn't evidence of absence (thank you, Price Pritchett).The iceberg model of manifestation (Freud meets manifestation).How your Reticular Activating System can either help or sabotage your manifestation.Why surrender is the secret to speeding things up.How to keep your signal clean, stay in alignment, and hold the vibe — even when nothing is showing up… yet.

The incidence of early onset colorectal cancer (EOCRC) has been rising prompting the change in change in screening guidelines to 45 years of age for average risk patients. Join us for an in-depth discussion with guest speakers Dr. Andrea Cercek and Dr. Nancy You, where we provide a comprehensive look at the growing challenge of EOCRC. Hosts: - Dr. Janet Alvarez - General Surgery Resident at New York Medical College/Metropolitan Hospital Center - Dr. Wini Zambare – General Surgery Resident at Weill Cornell Medical Center/New York Presbyterian - Dr. Phil Bauer, Graduating Colorectal Surgical Oncology Fellow at Memorial Sloan Kettering Cancer Center  - Dr. J. Joshua Smith MD, PhD, Chair, Department of Colon and Rectal Surgery at MD Anderson Cancer Center - Dr. Andrea Cercek - Gastrointestinal Medical Oncologist at Memorial Sloan Kettering Cancer Center - Dr. Y. Nancy You, MD MHSc - Professor, Department of Colon and Rectal Surgery at MD Anderson Cancer Center Learning objectives:  - Describe trends in incidence of colorectal cancer, with emphasis on the rise of EOCRC. - Identify age groups and demographics most affected by EOCRC. - Summarize USPSTF recommendations for colorectal cancer screening. - Distinguish between screening methods (e.g., colonoscopy, FIT-DNA) and their sensitivity. - Understand treatment approaches for colon and rectal cancer (CRC) - Understand the role of mismatch repair (MMR) status in guiding treatment. - Outline the importance of genetic counseling and testing in young patients. - Discuss racial, ethnic, and socioeconomic disparities in CRC incidence and outcomes. - Describe the impact of cancer treatment on fertility and sexual health. -  Review fertility preservation options. - Identify the value of integrated care teams for young CRC patients. References: 1.         Siegel, R. L. et al. Colorectal Cancer Incidence Patterns in the United States, 1974–2013. JNCI J. Natl. Cancer Inst. 109, djw322 (2017). https://pubmed.ncbi.nlm.nih.gov/28376186/ 2.         Abboud, Y. et al. Rising Incidence and Mortality of Early-Onset Colorectal Cancer in Young Cohorts Associated with Delayed Diagnosis. Cancers 17, 1500 (2025). https://pubmed.ncbi.nlm.nih.gov/40361427/ 3.         Phang, R. et al. Is the Incidence of Early-Onset Adenocarcinomas in Aotearoa New Zealand Increasing? Asia Pac. J. Clin. Oncol.https://pubmed.ncbi.nlm.nih.gov/40384533/ 4.         Vitaloni, M. et al. Clinical challenges and patient experiences in early-onset colorectal cancer: insights from seven European countries. BMC Gastroenterol. 25, 378 (2025). https://pubmed.ncbi.nlm.nih.gov/40375142/ 5.         Siegel, R. L. et al. Global patterns and trends in colorectal cancer incidence in young adults. (2019) doi:10.1136/gutjnl-2019-319511. https://pubmed.ncbi.nlm.nih.gov/31488504/ 6.         Cercek, A. et al. A Comprehensive Comparison of Early-Onset and Average-Onset Colorectal Cancers. J. Natl. Cancer Inst. 113, 1683–1692 (2021). https://pubmed.ncbi.nlm.nih.gov/34405229/ 7.         Zheng, X. et al. Comprehensive Assessment of Diet Quality and Risk of Precursors of Early-Onset Colorectal Cancer. JNCI J. Natl. Cancer Inst. 113, 543–552 (2021). https://pubmed.ncbi.nlm.nih.gov/33136160/ 8.         Standl, E. & Schnell, O. Increased Risk of Cancer—An Integral Component of the Cardio–Renal–Metabolic Disease Cluster and Its Management. Cells 14, 564 (2025). https://pubmed.ncbi.nlm.nih.gov/40277890/ 9.         Muller, C., Ihionkhan, E., Stoffel, E. M. & Kupfer, S. S. Disparities in Early-Onset Colorectal Cancer. Cells 10, 1018 (2021). https://pubmed.ncbi.nlm.nih.gov/33925893/ 10.       US Preventive Services Task Force. Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. JAMA 325, 1965–1977 (2021). https://pubmed.ncbi.nlm.nih.gov/34003218/ 11.       Fwelo, P. et al. Differential Colorectal Cancer Mortality Across Racial and Ethnic Groups: Impact of Socioeconomic Status, Clinicopathology, and Treatment-Related Factors. Cancer Med. 14, e70612 (2025). https://pubmed.ncbi.nlm.nih.gov/40040375/ 12.       Lansdorp-Vogelaar, I. et al. Contribution of Screening and Survival Differences to Racial Disparities in Colorectal Cancer Rates. Cancer Epidemiol. Biomarkers Prev. 21, 728–736 (2012). https://pubmed.ncbi.nlm.nih.gov/22514249/ 13.       Ko, T. M. et al. Low neighborhood socioeconomic status is associated with poor outcomes in young adults with colorectal cancer. Surgery 176, 626–632 (2024). https://pubmed.ncbi.nlm.nih.gov/38972769/ 14.       Siegel, R. L., Wagle, N. S., Cercek, A., Smith, R. A. & Jemal, A. Colorectal cancer statistics, 2023. CA. Cancer J. Clin. 73, 233–254 (2023). https://pubmed.ncbi.nlm.nih.gov/36856579/ 15.       Jain, S., Maque, J., Galoosian, A., Osuna-Garcia, A. & May, F. P. Optimal Strategies for Colorectal Cancer Screening. Curr. Treat. Options Oncol. 23, 474–493 (2022). https://pubmed.ncbi.nlm.nih.gov/35316477/ 16.       Zauber, A. G. The Impact of Screening on Colorectal Cancer Mortality and Incidence: Has It Really Made a Difference? Dig. Dis. Sci. 60, 681–691 (2015). https://pubmed.ncbi.nlm.nih.gov/25740556/ 17.       Edwards, B. K. et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 116, 544–573 (2010). https://pubmed.ncbi.nlm.nih.gov/19998273/ 18.       Cercek, A. et al. Nonoperative Management of Mismatch Repair–Deficient Tumors. New England Journal of Medicine 392, 2297–2308 (2025). https://pubmed.ncbi.nlm.nih.gov/40293177/ 19.       Monge, C., Waldrup, B., Carranza, F. G. & Velazquez-Villarreal, E. Molecular Heterogeneity in Early-Onset Colorectal Cancer: Pathway-Specific Insights in High-Risk Populations. Cancers 17, 1325 (2025). https://pubmed.ncbi.nlm.nih.gov/40282501/ 20.       Monge, C., Waldrup, B., Carranza, F. G. & Velazquez-Villarreal, E. Ethnicity-Specific Molecular Alterations in MAPK and JAK/STAT Pathways in Early-Onset Colorectal Cancer. Cancers 17, 1093 (2025). https://pubmed.ncbi.nlm.nih.gov/40227607/ 21.       Benson, A. B. et al. Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J. Natl. Compr. Cancer Netw. JNCCN 19, 329–359 (2021). https://pubmed.ncbi.nlm.nih.gov/33724754/ 22.       Christenson, E. S. et al. Nivolumab and Relatlimab for the treatment of patients with unresectable or metastatic mismatch repair proficient colorectal cancer. https://pubmed.ncbi.nlm.nih.gov/40388545/ 23.       Dasari, A. et al. Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study. The Lancet 402, 41–53 (2023). https://pubmed.ncbi.nlm.nih.gov/37331369/ 24.       Strickler, J. H. et al. Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 study. Lancet Oncol. 24, 496–508 (2023). https://pubmed.ncbi.nlm.nih.gov/37142372/ 25.       Sauer, R. et al. Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer. N. Engl. J. Med. 351, 1731–1740 (2004). https://pubmed.ncbi.nlm.nih.gov/15496622/ 26.       Cercek, A. et al. Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer. JAMA Oncol. 4, e180071 (2018). https://pubmed.ncbi.nlm.nih.gov/29566109/ 27.       Garcia-Aguilar, J. et al. Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy. J. Clin. Oncol. 40, 2546–2556 (2022). https://pubmed.ncbi.nlm.nih.gov/35483010/ 28.       Schrag, D. et al. Preoperative Treatment of Locally Advanced Rectal Cancer. N. Engl. J. Med. 389, 322–334 (2023). https://pubmed.ncbi.nlm.nih.gov/37272534/ 29.       Kunkler, I. H., Williams, L. J., Jack, W. J. L., Cameron, D. A. & Dixon, J. M. Breast-Conserving Surgery with or without Irradiation in Early Breast Cancer. N. Engl. J. Med. 388, 585–594 (2023). https://pubmed.ncbi.nlm.nih.gov/36791159/ 30.       Jacobsen, R. L., Macpherson, C. F., Pflugeisen, B. M. & Johnson, R. H. Care Experience, by Site of Care, for Adolescents and Young Adults With Cancer. JCO Oncol. Pract. (2021) doi:10.1200/OP.20.00840. https://pubmed.ncbi.nlm.nih.gov/33566700/ 31.       Ruddy, K. J. et al. Prospective Study of Fertility Concerns and Preservation Strategies in Young Women With Breast Cancer. J. Clin. Oncol. (2014) doi:10.1200/JCO.2013.52.8877. https://pubmed.ncbi.nlm.nih.gov/24567428/ 32.       Su, H. I. et al. Fertility Preservation in People With Cancer: ASCO Guideline Update. J. Clin. Oncol. 43, 1488–1515 (2025). https://pubmed.ncbi.nlm.nih.gov/40106739/ 33.       Smith, K. L., Gracia, C., Sokalska, A. & Moore, H. Advances in Fertility Preservation for Young Women With Cancer. Am. Soc. Clin. Oncol. Educ. Book 27–37 (2018) doi:10.1200/EDBK_208301. https://pubmed.ncbi.nlm.nih.gov/30231357/ 34.       Blumenfeld, Z. How to Preserve Fertility in Young Women Exposed to Chemotherapy? The Role of GnRH Agonist Cotreatment in Addition to Cryopreservation of Embrya, Oocytes, or Ovaries. The Oncologist 12, 1044–1054 (2007). 35.       Bhagavath, B. The current and future state of surgery in reproductive endocrinology. Curr. Opin. Obstet. Gynecol. 34, 164 (2022). 36.       Ribeiro, R. et al. Uterine transposition: technique and a case report. Fertil. Steril. 108, 320-324.e1 (2017). 37.       Yazdani, A., Sweterlitsch, K. M., Kim, H., Flyckt, R. L. & Christianson, M. S. Surgical Innovations to Protect Fertility from Oncologic Pelvic Radiation Therapy: Ovarian Transposition and Uterine Fixation. J. Clin. Med. 13, 5577 (2024). 38.       Holowatyj, A. N., Eng, C. & Lewis, M. A. Incorporating Reproductive Health in the Clinical Management of Early-Onset Colorectal Cancer. JCO Oncol. Pract. 18, 169–172 (2022). ***Behind the Knife Colorectal Surgery Oral Board Audio Review: https://app.behindtheknife.org/course-details/colorectal-surgery-oral-board-audio-review Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

SummaryIn this episode of A Cup of Joe podcast, Joe Morton explores the interconnectedness of the reticular activating system (RAS) and the law of attraction, emphasizing the power of thoughts, emotions, and intentions in shaping our reality. He discusses how our beliefs and dominant thoughts filter our experiences and attract corresponding outcomes. The conversation delves into practical applications such as prayer, visualization, and mindfulness, highlighting the importance of setting intentions and nurturing a positive mindset to achieve personal goals and well-being. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit joemorton88.substack.com

MUSICDeftones will release their first album in five years, Private Music, on August 22nd. The first single is called "My Mind Is a Mountain," which you can check out on YouTube now. The album was produced by Nick Raskulinecz [pr: RAS-kell-in-ich], who sat in the producer's chair on 2010's Diamond Eyes and 2012's Koi No Yokan. https://www.youtube.com/watch?v=cgh_jEm5twE An old clip is resurfacing again from the Joe Rogan podcast where Jelly Roll sets some things straight. A bunch of people on the internet were calling his wife, Bunnie XO, a gold digger for being with him . . . but Jelly had the perfect answer. https://www.tiktok.com/@xomgitsbunnie/video/7234363257467817259 Jojo Siwa has teased a cover of Kim Carnes' classic '80s hit "Bette Davis Eyes", and Kim dissed it on an Instagram post that has since been deleted. Kim said "There's a difference between singing a song . . . And embodying it." Here's the clip Jojo posted. https://pagesix.com/2025/07/10/entertainment/kim-carnes-seemingly-shades-jojo-siwas-viral-betty-davis-eyes-cover/? The Yungblud documentary Are You Ready Boy? will be shown in theaters on August 20th and 24th. https://yungblud.film/ Ozzy Osbourne teamed up with some chimpanzees to create five paintings to sell at an auction to raise money for Save the Chimps. He says, quote, "I paint because it gives me peace of mind, but I don't sell my paintings. I've made an exception with these collaborations as it raises money for Save the Chimps . . . NEW ALBUM RELEASES:311 - 311 30th Anniversary Edition (two-LP set)Wet Leg - Moisturizer TVRick Springfield was disrespected not once, but TWICE on the "Today" show yesterday. The first diss happened before he even came out on the set. Al Roker was hyping Rick's appearance, and fellow hosts Savannah Guthrie, Jenna Bush Hager, and Kaylee Hartung started singing "867-5309 / Jenny". As EVERYONE should know, that's NOT a Rick Springfield song. It's by the FAR INFERIOR Tommy Tutone. https://www.dailymail.co.uk/media/article-14893911/today-rick-springfield-hosts-yawned-craig-melvin.html Check out a new trailer for the "King of the Hill" revival. https://www.hollywoodreporter.com/tv/tv-news/king-of-the-hill-revival-trailer-hulu-1236311177/ Larry David is returning to HBO one more time for a limited sketch comedy series about American history. David will star in six episodes. https://variety.com/2025/tv/news/larry-david-american-history-sketch-comedy-series-hbo-1236451946/ Tom Brady's representative has firmly denied claims that he ever said Sofía Vergara is “too old” to date him, calling such reports “pure fiction” and saying he “would never” make such a remark, according to People magazine. https://people.com/tom-brady-would-never-say-sofia-vergara-too-old-date-says-rep-exclusive-11770067?utm_source=chatgpt.com MOVING ON INTO MOVIE NEWS: IN THEATERS:Superman (Nicholas Hoult, Rachel Brosnahan, David Corenswet) The third installment of the 'Dune' franchise has an official title, 'Dune: Part Three.' Rumors spread that the movie would be called 'Dune Messiah', based off of the 1969 novel. https://variety.com/2025/film/news/dune-3-title-imax-cameras-1236448953/ AND FINALLYBefore some celebrities made it BIG, they did background work for movies, TV, and even music videos. BuzzFeed put together a list of some of these familiar faces. https://www.buzzfeed.com/trendyghost618/celebrities-who-started-as-extras AND THAT IS YOUR CRAP ON CELEBRITIES!See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

What if your brain has a built-in filtration system that's keeping you stuck in worry instead of manifesting your dreams? In this special bonus episode of Why Isn't Everyone Doing This?, I'm taking you deep into the science behind embodied manifesting and revealing why traditional manifestation techniques often fall short. Most people spend minutes every day "worshiping their worries"—obsessing over what could go wrong instead of focusing on what they'd love to create. But there's actual neuroscience behind why this happens, and more importantly, how to rewire it. I break down the reticular activating system (RAS), your brain's filter that determines what you notice in reality. When you're in chronic stress, this filter prioritizes threats over opportunities. But when you learn to regulate your nervous system first, then manifest from that grounded state, everything changes.